EUVIMEDEUVIMED entdecken
Crossref

Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period

Mirjana Kovac, Milena Todorovic Balint, Marija Milenkovic, Dusica Basaric, Branko Tomic, Bela Balint, Vera Ignjatovic

Hämostaseologie · 01.12.2025 · 45 (06) · 490-496

DOI: 10.1055/a-2238-4744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.12.2025. Verfasst von Mirjana Kovac und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Fibrin Fibrinogen Degradation Products, COVID-19, Factor VIII. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in the hemostatic system during COVID infection lead to hypercoagulability. Numerous studies have evaluated hemostatic abnormalities in COVID patients during acute infection, in the period of hospitalization. However, the hemostatic status following hospital discharge has not been sufficiently assessed. Considering the importance of FVIII and D-dimer levels as markers for the assessment of thrombosis, our study aimed to evaluate changes in these markers, as well as the influence of patient's age and clinical presentation of COVID infection on those hemostatic markers in the post-COVID phase. This prospective study (July 2020 to December 2022) included 115 COVID patients, 68 (59%) with asymptomatic/mild and 47 (41%) with moderate/severe clinical presentation. Patient follow-up included laboratory evaluation of FVIII and D-dimer levels at 1, 3, and 6 months following the COVID infection. Three months after the COVID infection, elevated FVIII was recorded in 44% of younger versus 65% of older individuals, p = 0.05, respectively, and 30 versus 57% (p = 0.008) 6 months post–COVID infection. With a focus on clinical presentation, a higher number of patients with moderate/severe COVID had elevated FVIII activity, but a statistically significant difference was observed only for the 6 months (32% mild vs. 53% moderate/severe, p = 0.041) post-infection time point. Following a COVID infection, an increase in FVIII activity suggests a continued hypercoagulable state in the post-COVID period and correlates with elevated D-dimer levels. This increase in FVIII is more pronounced in patients with moderate/severe clinical picture and those patients older than 50 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrin Fibrinogen Degradation ProductsCOVID-19Factor VIIIHumansMaleMiddle AgedFemaleAgedProspective StudiesSARS-CoV-2AdultBiomarkersAged, 80 and overThrombophilia

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment DFactor VIIIBiomarkers

Autor:innen und Institutionen

  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Department of Hemostasis, Blood Transfusion Institute of Serbia, Belgrade, Serbia.
  • Clinic for hematology, University Clinical Centre of Serbia, Belgrade, Serbia.
  • Emergency Centre, University Clinical Centre of Serbia, Belgrade, Serbia.
  • Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
  • Faculty of Medicine of the Military Medical Academy, University of Defense, Belgrade, Serbia.

Zitieren

APA

Kovac, M., Balint, M. T., Milenkovic, M., Basaric, D., Tomic, B., Balint, B., & Ignjatovic, V. (2025). Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period. Hämostaseologie, 45(06), 490-496. https://doi.org/10.1055/a-2238-4744

Vancouver

Kovac M, Balint MT, Milenkovic M, Basaric D, Tomic B, Balint B, et al. Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period. Hämostaseologie. 2025;45(06):490-496. doi:10.1055/a-2238-4744

BibTeX
@article{Kovac2025,
  author = {Kovac, Mirjana and Balint, Milena Todorovic and Milenkovic, Marija and Basaric, Dusica and Tomic, Branko and Balint, Bela and Ignjatovic, Vera},
  title = {Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period},
  journal = {Hämostaseologie},
  year = {2025},
  volume = {45},
  number = {06},
  pages = {490--496},
  doi = {10.1055/a-2238-4744}
}
Kostenlos starten →